Impact of Clonal Hematopoiesis of Undetermined Potential (CHIP) Mutations on Engraftment Kinetics After Autologous Stem Cell Transplantation in Multiple Myeloma Read more
Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations and Risk of Subsequent Myeloid Malignancies in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant (ASCT) Read more
Phase IB/II of CPX-351 as maintenance therapy in AML patients ineligible for bone marrow transplantation Read more
An Open-Label, Phase 1/2 Study of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004) Read more
A Global Multicenter, Open Label, Randomized, Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients with Chronic Phase Chronic Myeloid Leukemia (POLARIS-2) Read more
A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients With Relapsed or Refractory Acute Myeloid Leukemia Read more
